1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CELLECTIS - ADR
4.23 0.15 (3.68%)
21,558
XNAS Volume

XNAS 27 Jan, 2026 4:10 PM (EST)

Watchlist

Portfolio

Alert

Cellectis (ADR) - CLLS - stock price prediction, stock price target, analyst ratings from 6 analysts

Cellectis (ADR) has a share price target of US$ 7, revenue growth forecast of 55.6%, and profit growth estimate of -94.4% for FY25, based on top 6 analyst calls.